Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns
PHASE3CompletedINTERVENTIONAL
Enrollment
1,500
Participants
Timeline
Start Date
Not specified
Study Completion Date
November 30, 2004
Conditions
HIV Infections
Interventions
DRUG
Nevirapine
DRUG
Zidovudine
Trial Locations (1)
27709
Missie Allen, Research Triangle Park
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00006396 - Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns | Biotech Hunter | Biotech Hunter